CliffBio
small molecule

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Loss of exclusivityOctober 2032latest FDA-listed patent expiry
CompanyFresenius Kabi →View the full company profile on CliffBio

Drug detail

Brand nameLEVOTHYROXINE SODIUM
Active ingredientLEVOTHYROXINE SODIUM
Strength100MCG/VIAL
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusRX

Listed patents

PatentExpiresType
9006289October 2032product
9168239August 2032product
9168238August 2032product

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LEVOTHYROXINE SODIUM patent cliff — loss of exclusivity October 2032 | CliffBio